DK0830132T3 - Farmaceutisk formulering indeholdende tiagabinhydrochlorid samt fremgangsmåden til dets fremstilling - Google Patents

Farmaceutisk formulering indeholdende tiagabinhydrochlorid samt fremgangsmåden til dets fremstilling

Info

Publication number
DK0830132T3
DK0830132T3 DK96913473T DK96913473T DK0830132T3 DK 0830132 T3 DK0830132 T3 DK 0830132T3 DK 96913473 T DK96913473 T DK 96913473T DK 96913473 T DK96913473 T DK 96913473T DK 0830132 T3 DK0830132 T3 DK 0830132T3
Authority
DK
Denmark
Prior art keywords
preparation
well
pharmaceutical formulation
formulation containing
thiagabine
Prior art date
Application number
DK96913473T
Other languages
English (en)
Inventor
Lars Nygaard
Tina Meinertz Andersen
Helle Weibel
Thyge Borup Hjorth
Joergen Ryhl Svensson
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of DK0830132T3 publication Critical patent/DK0830132T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK96913473T 1995-05-05 1996-04-29 Farmaceutisk formulering indeholdende tiagabinhydrochlorid samt fremgangsmåden til dets fremstilling DK0830132T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK52395 1995-05-05
PCT/DK1996/000192 WO1996034606A1 (en) 1995-05-05 1996-04-29 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation

Publications (1)

Publication Number Publication Date
DK0830132T3 true DK0830132T3 (da) 2002-04-29

Family

ID=8094516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96913473T DK0830132T3 (da) 1995-05-05 1996-04-29 Farmaceutisk formulering indeholdende tiagabinhydrochlorid samt fremgangsmåden til dets fremstilling

Country Status (26)

Country Link
US (1) US5866590A (da)
EP (1) EP0830132B1 (da)
JP (1) JP3195360B2 (da)
KR (1) KR100440354B1 (da)
CN (1) CN1092959C (da)
AR (1) AR003418A1 (da)
AT (1) ATE211911T1 (da)
AU (1) AU707508B2 (da)
BR (1) BR9608120A (da)
CA (1) CA2220019C (da)
CZ (1) CZ292256B6 (da)
DE (1) DE69618586T2 (da)
DK (1) DK0830132T3 (da)
EG (1) EG23781A (da)
ES (1) ES2171669T3 (da)
HU (1) HU223075B1 (da)
IL (1) IL118142A (da)
MX (1) MX9708394A (da)
MY (1) MY115016A (da)
NO (1) NO318599B1 (da)
NZ (1) NZ307159A (da)
PL (1) PL183678B1 (da)
PT (1) PT830132E (da)
UA (1) UA43402C2 (da)
WO (1) WO1996034606A1 (da)
ZA (1) ZA963478B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
EP0991409B1 (en) * 1997-08-01 2002-01-30 ELAN CORPORATION, Plc Controlled release pharmaceutical compositions containing tiagabine
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
EP1017386A1 (en) * 1997-10-02 2000-07-12 H. Lundbeck A/S GRANULAR PREPARATIONS OF 5-(2-ETHYL- 2$i(H)-TETRAZOL- 5-YL)-1-METHYL-1, 2,3,6-TETRAHYDROPYRIDINE
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
ZA99407B (en) * 1998-01-22 1999-07-20 Abbott Lab Extended release tiagabine formulations with reduced side-effects.
AU2002325404B2 (en) * 1998-01-22 2006-02-02 Abbott Laboratories Extended Release Tiagabine Formulations with Reduced Side-effects
WO2001091751A1 (en) * 2000-05-30 2001-12-06 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
JP2004506609A (ja) 2000-05-26 2004-03-04 ノボ　ノルディスク　アクティーゼルスカブ 新たなる医薬組成物及びその調製の為の方法
WO2006067605A1 (en) * 2004-12-23 2006-06-29 Ranbaxy Laboratories Limited Stable pharmaceutical compositions of tiagabine and processes for their preparation
CN102125693A (zh) * 2011-01-25 2011-07-20 福建科瑞药业有限公司 一种盐酸噻加宾药物组合物及其制备方法
SG11201407309XA (en) * 2012-05-08 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy
JP6793651B2 (ja) * 2015-08-28 2020-12-02 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US501090A (en) * 1893-07-11 gennert
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies

Also Published As

Publication number Publication date
AR003418A1 (es) 1998-08-05
HUP9802741A3 (en) 1999-04-28
NZ307159A (en) 1998-10-28
CZ338897A3 (cs) 1998-03-18
EP0830132B1 (en) 2002-01-16
US5866590A (en) 1999-02-02
MX9708394A (es) 1998-02-28
CA2220019A1 (en) 1996-11-07
PL183678B1 (pl) 2002-06-28
WO1996034606A1 (en) 1996-11-07
CN1183721A (zh) 1998-06-03
ZA963478B (en) 1996-11-13
CN1092959C (zh) 2002-10-23
NO975076L (no) 1997-11-04
EP0830132A1 (en) 1998-03-25
AU5644196A (en) 1996-11-21
HUP9802741A2 (hu) 1999-03-29
BR9608120A (pt) 1999-02-09
EG23781A (en) 2007-08-13
UA43402C2 (uk) 2001-12-17
ATE211911T1 (de) 2002-02-15
CA2220019C (en) 2007-12-11
JPH10505359A (ja) 1998-05-26
NO318599B1 (no) 2005-04-18
MY115016A (en) 2003-03-31
NO975076D0 (no) 1997-11-04
IL118142A (en) 1999-11-30
CZ292256B6 (cs) 2003-08-13
DE69618586T2 (de) 2002-09-05
ES2171669T3 (es) 2002-09-16
KR100440354B1 (ko) 2004-09-18
PT830132E (pt) 2002-07-31
IL118142A0 (en) 1996-09-12
JP3195360B2 (ja) 2001-08-06
HU223075B1 (hu) 2004-03-01
PL323138A1 (en) 1998-03-16
AU707508B2 (en) 1999-07-15
DE69618586D1 (de) 2002-02-21

Similar Documents

Publication Publication Date Title
DK0807111T3 (da) Substituerede heterocykliske forbindelser, fremgangsmåde til fremstillingen heraf samt farmaceutiske sammensætninger indeholdende disse
DK0812195T3 (da) Farmaceutisk sammensætning til piperidinoalkanolforbindelser
HUP9603494A3 (en) Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof
HUP0001539A3 (en) 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
GR3031304T3 (en) 6-Dimethylaminomethyl-1-phenyl-cyclo-hexane compounds as pharmaceutical agents
TR199600792A2 (tr) Dihaloazolopirimidinlerin hazirlanmasina yönelik proses.
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
HU9603495D0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
NO973923D0 (no) Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
NO20004345D0 (no) Farmasøytisk sammensetning
MA23395A1 (fr) Procede de preparation de nouvelles formulations
BR9610396A (pt) Formulação farmacêutica
DK0830132T3 (da) Farmaceutisk formulering indeholdende tiagabinhydrochlorid samt fremgangsmåden til dets fremstilling
EE03351B1 (et) Meetod lerkanidipiinhüdrokloriidi valmistamiseks
HUP9802393A3 (en) Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediates
FI961378A0 (fi) Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi
NO974563D0 (no) Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
GB9523566D0 (en) Pharmaceutical formulation
ITMI931680A1 (it) Procedimento per la preparazione di alcansolfonammidi
FI973280A (fi) Farmaseuttinen koostumus
ZA96526B (en) Novel pharmaceutical formulation
HUP9702395A3 (en) Prokinetic oxadiazoles, process for their preparation, intermediates and pharmaceutical compositions containing the same
NO20003393L (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
FI974002A (fi) Menetelmä ranitidiinihydrokloridi 1 muodon valmistamiseksi